Nonenzymatically glycated lipoprotein ApoA-I in plasma of diabetic and nephropathic patients

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 295-299

  Lapolla, Annunziata ^a   Brioschi, Maura ^b,c   Banfi, Cristina ^b,c   Tremoli, Elena ^b,c   Cosma, Chiara ^a   Bonfante, Luciana ^a   Cristoni, Simone ^b,d   Seraglia, Roberta ^e   Traldi, Pietro ^e  

^a UNIVERSITY OF PADOVA   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d ISB   (Italy)

^e CNR   (Italy)

Author keywords

2D gel electrophoresis; Diabetes; MALDI MS; Nephropathy; Nonenzymatic glycation

Indexed keywords

APOLIPOPROTEIN A1;

ADULT; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC PATIENT; GLYCATION; HUMAN; KIDNEY DISEASE; LIPOPROTEIN BLOOD LEVEL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 42549085587     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.005     Document Type: Conference Paper

References (21)

1. 1 Castelli, W.P., R.J. Garrison, P.W. Wilson, et al. 1986. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham study. JAMA 256: 2835–2838.
2. 2 Lewis, G.F. & D.J. Rader. 2005. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96: 1221–1232.
3. 3 Rader, D. 2003. Regulation of reverse cholesterol transport and clinical implications. Am. J. Cardiol. 92: 42J–49J.
4. 4 Roher, L., M. Hersberger & A. Von Eckardstein. 2004. High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr. Opin. Lipidol. 15: 269–278.
5. 5 Quintao, E.C., W.L. Medina & M. Passarelli. 2000. Reverse cholesterol transport in diabetes mellitus. Diabetes Metab. Res. Rev. 16: 237–250.
6. 6 Batista, M.C., F.K. Welty, M.R. Diffenderfer, et al. 2004. Apolipoprotein A‐I, B‐100 and B‐48 metabolism in subjects with chronic kidney disease, obesity and the metabolic syndrome. Metabolism 53: 1255–1261.
7. 7 Okubo, K., K. Ikewaki, S. Sakai, et al. 2004. Abnormal HDL apolipoprotein A‐I and A‐II kinetics in hemodialysis patients: a stable isotope study. J. Am. Soc. Nephrol. 15: 1008–1015.
8. 8 Calvo, C., G. Ponsin & F. Berthezene. 1988. Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients. Diabete Metab. 14: 264–269.
9. 9 Calvo, C., C. Talussot, G. Ponsin, et al. 1988. Nonenzymatic glycation of apolipoprotein A‐I. Effects on its self‐association and lipid binding properties. Biochem. Biophys. Res. Commun. 153: 1060–1067.
10. 10 Calvo, C. & C. Verdugo. 1992. Association in vivo of glycated apolipoprotein A‐I with high density lipoproteins. Eur. J. Clin. Chem. Clin. Biochem. 30: 3–5.
11. 11 Shishino, K., M. Murase, S. Makino, et al. 2000. Glycated apolipoprotein A‐I assay by combination of affinity chromatography and latex immunoagglutination. Ann. Clin. Biochem. 37: 498–506.
12. 12 Harper, R.G., S.R. Workman, S. Schuetzner, et al. 2004. Low‐molecular‐weight human serum proteome using ultrafiltration, isoelectric focusing and mass spectrometry. Electrophoresis 25: 1299–1306.
13. 13 Banfi, C., M. Brioschi, R. Wait, et al. 2006. Proteomic analysis of membrane microdomains derived from both failing and non‐failing human hearts. Proteomics 6: 1976–1988.
14. 14 Shevchenko, A., M. Wilm, O. Vorm, et al. 1996. Mass spectrometric sequencing of proteins from silver stained polyacrylamide gels. Anal. Chem. 68: 850–858.
15. 15 Moneti, G., F. Francese, G. Mastrobuoni, et al. 2007. Do collisions inside the collision cell play a relevant role in CID‐LIFT experiments? J. Mass Spectrom. 42: 117–126.
16. 16 http://www.expasy.org/tools/aldente/
17. 17 http://prowl.rockefeller.edu/
18. 18 http://www.expasy.ch/tools/glycomod/
19. 19 http://peptide.ucsd.edu/
20. 20 Tanner, S., H. Shu, A. Frank, et al. 2005. InsPecT: Fast and accurate identification of post‐translationally modified peptides from tandem mass spectra. Anal. Chem. 77: 4626–4639.
21. 21 Lapolla, A., D. Fedele, R. Seraglia, et al. 2006. The role of mass spectrometry in the study of non‐enzymatic protein glycation in diabetes: an update. Mass Spectrom. Rev. 25: 775–797.